Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative)

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - Therakine Biodelivery GmbH [Member]
Oct. 12, 2018
USD ($)
Patent acquired $ 15,200
Development, Commerialization and License agreement, description <p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Patent families consisting of approximately 11 patents pending and 1 issued patent.</font></p>